Spiriva market share for FY25, our target was somewhere around 35% - 40%. In December, as for the presentation, it's around 30% - 31%. So what are the plans for Spiriva market share at this stage, including commercial versus Medicare and Medicaid channel?
Just one clarification on this incremental ma rket share that is standing out, earlier mentioned that at a commercial level, you were already at 40% plus. So this incremental market share is sort of coming from the non -commercial side of the business?